Mani Sundararajan, Ph.D., joined Fulcrum in July 2021 as senior vice president, technical operations. Most recently he worked at Seagen, where he led several technical operations functions including small molecules process development, CMC strategy and program management. He has also held leadership positions in drug development and technical operations at Takeda, Shire, AstraZeneca, Bristol-Myers Squibb and DuPont Pharmaceuticals. Mani has a B.Sc.(Tech.) in pharmaceuticals & fine chemicals technology from the Institute of Chemical Technology at University of Mumbai, India, an M.S. and Ph.D. in pharmaceutical sciences from Temple University, and an executive masters in technology management from University of Pennsylvania’s School of Engineering & Applied Science and Wharton.